US2006002908A1PendingUtilityA1
Bifidobacterium in the treatment of inflammatory disease
Est. expiryJan 15, 2019(expired)· nominal 20-yr term from priority
A61P 43/00A61P 37/02A61P 37/04A61P 37/06A61P 37/00A61P 35/00A61P 31/12A61P 31/04A61P 31/14A61P 29/00A61P 19/04Y10S435/822A61K 2039/542A61P 1/12C12N 1/20A23V 2002/00Y10S435/853A23L 33/135A61K 39/09A61P 1/04A61K 2039/52A61P 19/02A61P 1/00C12R 2001/01C12N 1/205A23C 9/1234A23V 2400/179
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatroy activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer.
Claims
exact text as granted — not AI-modified1 - 54 . (canceled)
55 . An antimicrobial agent obtained from a strain of Bifidobacterium isolated from a resected and washed human gastrointestinal tract which is significantly immunomodulatory following oral consumption in humans.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.